State of Michigan   Report issue

Government Phase 1 Phase 2
Founded: Lansing MI United States (1837)

Organization Overview

First Clinical Trial
2018
NCT03582722
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Detroit Department of Health | Michigan Public Health Departments | Substance Abuse and Mental Health Services Administration (SAMHSA)

Active Ingredients

Drugs in Phase 2 Trials (1)

orlistat (xenical) (1 trial)

Drugs in Phase 1 Trials (3)

cannabidiol (Epidiolex) (1 trial)

cannabis (1 trial)

tetrahydrocannabinol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Poisoning (Phase 2)

Weight Loss (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4